UNSPSC 51386204: Diacerein

This classification denotes a log with the molecular formula C19H12O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4HU6J11EL5. European Medicines Agency schedules diacerein in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07060MIG. The term DIACEREIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24). DIACEREIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule diacerein under HS 29189900 and SITC 51396. As of Q4 2014, DIACEREIN remains the US FDA Preferred Term for this commodity. SMILES: O(C1C2C(C(=O)C3C(C2=O)C(OC(=O)C)CCC3)CC(C1)C(=O)O)C(=O)C.

UNSPSC 51386204 Diacerein, a Commodity code, does not align with the state and local procurement activity posted under it. The single recent opportunity — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 — solicits naloxone and safe drug deactivation systems for community health support, a pharmaceutical and harm-reduction product line unrelated to diacerein, which is an osteoarthritis medication. The mismatch suggests a coding error or misclassification in the county's procurement system rather than genuine demand for diacerein under this code.

No recent state and local opportunities reflect procurement of diacerein itself. The single posted solicitation is a Seminole County, Florida IFB for naloxone (1,900 units annually) and drug deactivation systems (800 units annually) with quarterly deliveries to the Seminole County Community Health Building in Sanford, due July 26, 2023. Without additional opportunities demonstrating genuine market activity for diacerein at the state and local level, this code presents no actionable pursuit signal for business development professionals focused on arthritis pharmaceuticals or related therapeutics.